We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+7.94%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.8B
AUM Growth
+$401M
(+2%)
Cap. Flow
-$819M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
34.88%
Holding
872
New
34
Increased
469
Reduced
316
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$311M |
| 2 |
Chevron
CVX
|
+$78M |
| 3 |
TSMC
TSM
|
+$55.6M |
| 4 |
Core Laboratories
CLB
|
+$42.1M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GG
Goldcorp Inc
GG
|
+$586M |
| 2 |
B
Barrick Mining
B
|
+$128M |
| 3 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$86.9M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$74.7M |
| 5 |
Kinross Gold
KGC
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 55.1% |
| 2 | Energy | 8.94% |
| 3 | Technology | 8.27% |
| 4 | Healthcare | 6.04% |
| 5 | Financials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Patterson-UTI
PTEN
$3.87B
| $46.7M | 0.23% |
4,058,874
-1,147,253
| -22% | -$14.8M |
|
102
Lam Research
LRCX
$382B
| $45M | 0.22% |
2,397,180
+319,960
| +15% | +$6.07M |
|
|
WPX
103
DELISTED
WPX Energy, Inc.
WPX
| $43M | 0.21% |
3,733,932
+821,183
| +28% | +$10.2M |
|
104
Ares Capital
ARCC
$13.5B
| $42.3M | 0.2% |
2,356,362
+64,715
| +3% | +$1.15M |
|
105
TechnipFMC
FTI
$30.6B
| $42.1M | 0.2% |
2,180,881
-295,498
| -12% | -$5.18M |
|
106
Walt Disney
DIS
$165B
| $42.1M | 0.2% |
301,274
-196,817
| -40% | -$26.1M |
|
107
Tenaris
TS
$29.1B
| $42M | 0.2% |
1,597,923
+94,100
| +6% | +$2.52M |
|
|
MAG
108
DELISTED
MAG Silver
MAG
| $41.4M | 0.2% |
3,931,156
+160,423
| +4% | +$1.61M |
|
109
McKesson
MCK
$98.5B
| $40.6M | 0.2% |
302,173
-247,921
| -45% | -$30.9M |
|
|
SA
110
Seabridge Gold
SA
$2.8B
| $40.2M | 0.19% |
2,968,290
+29,522
| +1% | +$350K |
|
111
Bristol-Myers Squibb
BMY
$127B
| $40M | 0.19% |
882,639
+154,830
| +21% | +$7.21M |
|
112
Baker Hughes
BKR
$56.8B
| $39.6M | 0.19% |
1,609,728
+68,601
| +4% | +$1.65M |
|
113
NOV
NOV
$7.45B
| $38.8M | 0.19% |
1,746,021
+262,070
| +18% | +$6.33M |
|
114
Microsoft
MSFT
$2.84T
| $38.8M | 0.19% |
289,450
+5,584
| +2% | +$709K |
|
115
Pfizer
PFE
$140B
| $38.7M | 0.19% |
940,716
+7,921
| +0.8% | +$315K |
|
|
RDS.B
116
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $38.4M | 0.19% |
+584,700
| New | +$38M |
|
|
ESV
117
DELISTED
Ensco Rowan plc
ESV
| $38.4M | 0.18% |
4,498,790
+3,157,906
| +236% | +$36.5M |
|
118
PBF Energy
PBF
$7.29B
| $38.1M | 0.18% |
1,217,755
+599,870
| +97% | +$17.9M |
|
119
Mondelez International
MDLZ
$77.7B
| $37.9M | 0.18% |
702,666
-545,553
| -44% | -$28.3M |
|
120
Bunge Global
BG
$23.6B
| $37.7M | 0.18% |
677,483
-108,831
| -14% | -$5.8M |
|
121
Viper Energy
VNOM
$8.81B
| $37.4M | 0.18% |
1,213,200
-104,700
| -8% | -$3.24M |
|
|
MDR
122
DELISTED
McDermott International
MDR
| $37.4M | 0.18% |
3,866,611
+956,869
| +33% | +$7.64M |
|
123
Cencora
COR
$60.3B
| $37.2M | 0.18% |
436,323
-374,291
| -46% | -$29.6M |
|
124
Idexx Laboratories
IDXX
$42.9B
| $36.9M | 0.18% |
133,962
-42,549
| -24% | -$10.5M |
|
125
Oceaneering
OII
$5.25B
| $36.7M | 0.18% |
1,800,526
+647,261
| +56% | +$11.5M |
|
Similar funds
DAM
VanEck Associates's Q2 2019 Portfolio in Review
As of Q2 2019, VanEck Associates held 872 positions worth $20.8B, up 2% from $20.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
VanEck Associates withdrew a net $819M in Q2 2019, closing 42 positions and reducing 316 holdings. Its most notable exit was Goldcorp Inc, an estimated $586M position sold in full.
By sector, the portfolio is most concentrated in Materials at 55% of assets, down from 56% a quarter earlier, followed by Energy and Technology.
Against the trend, VanEck Associates opened a new position in Royal Dutch Shell PLC ADS Class B worth $38.4M.
- VanEck Associates's largest Q2 2019 buy was Royal Dutch Shell PLC ADS Class B: 584,700 shares worth $38.4M.
- VanEck Associates added most to Newmont in Q2 2019, an estimated $311M increase.
- VanEck Associates's biggest Q2 2019 reduction was Barrick Mining, cutting an estimated $128M.
- VanEck Associates fully exited Goldcorp Inc in Q2 2019, selling an estimated $586M.
- VanEck Associates's ten largest holdings make up 35% of its $20.8B portfolio in Q2 2019.
- VanEck Associates opened 34 new positions and closed 42 in Q2 2019.
- VanEck Associates's portfolio value rose 2% quarter-over-quarter to $20.8B.
Based on VanEck Associates's 13F filing for Q2 2019, filed 7 Aug 2019.